Kazia Therapeutics Limited (NASDAQ:KZIA)

Novogen Limited is an Australian biotechnology company based in Sydney, Australia. Novogen conducts research and development on oncology therapeutics through its subsidiary, Marshall Edwards, Inc., and is developing glucan technology through its subsidiary, Glycotex, Inc. More information on the Novogen group of companies can be found at www.novogen.com.

Web site: http://www.novogen.com

Last updated October 5, 2012


Market Data powered by QuoteMedia. Terms of Use